Tresiba

List of products in the National Drug Code with proprietary name tresiba. Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0169-2550Tresiba Insulin DegludecInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0169-2660Tresiba Insulin DegludecInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0169-2662Tresiba Insulin DegludecInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
50090-3491Tresiba Insulin DegludecInjection, SolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-7077Tresiba Insulin DegludecInjection, SolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-7094Tresiba Insulin DegludecInjection, SolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug